🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rama Raghunandan

Program for Appropriate Technology in Health

ORCID: 0000-0001-8254-0809
MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial”.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101323
N/A
1.3DataRank · unranked
55 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

medRxiv(2021)10.1101/2021.09.17.21263758
N/A
0.486DataRank · unranked
8 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial

Vaccine(2024)10.1016/j.vaccine.2024.126542
N/A
0.104DataRank · unranked
1 citations

Đặng Đức Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, José Mateus +14 more

Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

medRxiv(2022)10.1101/2022.02.01.22270253
N/A
0DataRank · unranked
3 citations

Vũ Đình Thiểm, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thị Ngọc Đặng +28 more